SQZ Biotech Launches Cellsqueeze Platform And Is Awarded $100,000 Grand Prize From Masschallenge And Over $200,000 From Boeing And The Center For The Advancement Of Science In Space (CASIS)

BOSTON--(BUSINESS WIRE)--SQZ Biotech has been awarded a $100,000 grand prize in MassChallenge’s 2014 startup competition at the accelerator’s annual awards ceremony. The Company was founded to commercialize CellSqueeze, an innovative platform that enables virtually any material to enter a cell with unprecedented efficiency through a gentle squeeze. This capability has many applications in biomedical research and drug development, including studying disease mechanisms, identifying novel drugs and engineering cell function for therapeutic use. The Company was selected from a pool of Top 26 Startups announced earlier in October, which were chosen from 1,650 applicants from all over the world. MassChallenge is the world’s largest startup accelerator and first to support high-impact, early-stage entrepreneurs with no strings attached.

Help employers find you! Check out all the jobs and post your resume.

MORE ON THIS TOPIC